Release Date: 06/08/09 08:41 Summary: CWT FY09 Results Presentation Price Sensitive: No Download Document 454.81KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%